Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#191 / 200 Total
ORMP - Oramed Pharmaceuticals, Inc - Stock Price Chart
TickerORMP [NASD]
CompanyOramed Pharmaceuticals, Inc
CountryUSA
IndustryBiotechnology
Market Cap99.68MEPS (ttm)0.14
P/E18.07EPS this Y2.38%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S74.39EPS next 5Y-
P/B0.61EPS Q/Q252.63%
Dividend-Sales Q/Q-100.00%
Insider Own14.35%Inst Own12.33%
Insider Trans0.00%Inst Trans-39.92%
Short Float1.06%Earnings-
Analyst Recom3.00Target Price4.25
Avg Volume171.09K52W Range1.67 - 5.25
Mar-19-24 09:00AM Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation (GlobeNewswire)
Mar-07-24 10:53AM ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023 (InvestorPlace)
Feb-20-24 08:30AM Oramed Letter to Shareholders (PR Newswire)
Nov-10-23 05:03AM Oramed: Q3 Earnings Snapshot (Associated Press Finance)
Oct-24-23 08:30AM PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization (PR Newswire)
Oct-05-23 10:13AM ORMP: Distribution Deals, JVs in Anticipation of Commercializing ORMD-0801 (Zacks)
Sep-22-23 11:38AM Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company (PR Newswire)
Sep-21-23 06:11PM Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company (PR Newswire)
04:05PM Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc. (GlobeNewswire)
Sep-13-23 09:00AM Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder (GlobeNewswire) -5.56%
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
SITM - SiTime Corp - Stock Price Chart
TickerSITM [NASD, RUT]
CompanySiTime Corp
CountryUSA
IndustrySemiconductors
Market Cap2.03BEPS (ttm)-3.63
P/E-EPS this Y224.35%
Forward P/E51.35EPS next Y196.18%
PEG-EPS past 5Y-42.16%
P/S14.10EPS next 5Y6.90%
P/B2.85EPS Q/Q-1150.63%
Dividend-Sales Q/Q-30.30%
Insider Own24.09%Inst Own83.59%
Insider Trans-7.79%Inst Trans3.62%
Short Float7.45%EarningsMay 08/a
Analyst Recom1.71Target Price143.50
Avg Volume222.94K52W Range72.39 - 141.99
SiTime Corp.is a micro-electromechanical system-based silicon timing solution. The company is transforming the timing industry with configurable solutions that replace legacy quartz devices and enable customers to differentiate their products with performance, smaller size, lower power, and reliability. The company was founded by Markus Lutz and Aaron Partridge on December 3, 2003 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Assaderaghi FariborzSee RemarksMar 27 '24Sale90.571,288116,661111,491Mar 28 04:10 PM
Assaderaghi FariborzSee RemarksFeb 29 '24Sale92.331,02694,72590,887Mar 01 05:30 PM
Bonnot LionelSee RemarksFeb 29 '24Sale95.0926024,72377,188Mar 01 05:28 PM
MEGACHIPS CORP /FI10% OwnerFeb 15 '24Sale104.25450,00046,912,5004,250,000Feb 20 04:30 PM
Assaderaghi FariborzSee RemarksJan 29 '24Sale116.371,026119,39694,056Jan 31 09:20 PM
MRIN - Marin Software Inc - Stock Price Chart
TickerMRIN [NASD]
CompanyMarin Software Inc
CountryUSA
IndustrySoftware - Application
Market Cap7.59MEPS (ttm)-7.46
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y29.51%
P/S0.43EPS next 5Y20.00%
P/B0.56EPS Q/Q1.88%
Dividend-Sales Q/Q-15.71%
Insider Own7.64%Inst Own9.70%
Insider Trans0.00%Inst Trans-
Short Float1.73%EarningsMay 02/a
Analyst Recom3.00Target Price2.00
Avg Volume739.87K52W Range1.44 - 5.45
Marin Software, Inc. is a cloud-based digital advertising management company. It provides a cross-channel, cross-device, enterprise marketing software platform for search, social, and display advertising channels, offered as a software-as-a-service. The firm's integrated platform is an analytics, workflow, and optimization solution for marketing professionals to manage digital advertising spend across search and display advertising channels. The company was founded by Christopher A. Lien, Paul M. Butler, Joseph Chang, and Wister Walcott on March 16, 2006 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CROVITZ L GORDONDirectorApr 05 '24Option Exercise0.0054,0320189,919Apr 11 05:11 PM
Hutchison Donald P.DirectorApr 05 '24Option Exercise0.0054,0320189,919Apr 11 05:12 PM
Middleton DainaDirectorApr 05 '24Option Exercise0.0054,0320217,891Apr 11 05:13 PM
Mann Diena LeeDirectorApr 05 '24Option Exercise0.0060,8190112,461Apr 11 05:14 PM
Kinion Brian KDirectorApr 05 '24Option Exercise0.0054,0320202,891Apr 11 05:15 PM
OCEA - Ocean Biomedical Inc. - Stock Price Chart
TickerOCEA [NASD, RUT]
CompanyOcean Biomedical Inc.
CountryUSA
IndustryBiotechnology
Market Cap46.43MEPS (ttm)-3.83
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-587.66%
Dividend-Sales Q/Q-
Insider Own74.86%Inst Own13.49%
Insider Trans0.00%Inst Trans2.64%
Short Float7.39%Earnings-
Analyst Recom1.00Target Price18.50
Avg Volume6.80M52W Range0.52 - 12.08
Apr-24-24 04:51PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K (GlobeNewswire)
Mar-28-24 01:15PM 13 Hot Stocks to Invest in According to Wall Street Analysts (Insider Monkey) -6.77%
08:01AM Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL (GlobeNewswire)
Mar-24-24 03:52PM 5 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Mar-05-24 08:30AM Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments (GlobeNewswire) +28.92%
Feb-29-24 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting (GlobeNewswire) +14.29%
Dec-05-23 09:45AM EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody (Benzinga)
08:15AM Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody (GlobeNewswire)
Nov-29-23 05:41PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire) -8.95%
Nov-14-23 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics (GlobeNewswire) -15.36%
Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria in June 2021 and is headquartered in Providence, RI.
KROS - Keros Therapeutics Inc - Stock Price Chart
TickerKROS [NASD, RUT]
CompanyKeros Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.08BEPS (ttm)-5.19
P/E-EPS this Y-1.34%
Forward P/E-EPS next Y-4.48%
PEG-EPS past 5Y-111.11%
P/S13878.69EPS next 5Y-
P/B5.55EPS Q/Q-22.83%
Dividend-Sales Q/Q-
Insider Own23.95%Inst Own69.19%
Insider Trans-0.46%Inst Trans2.79%
Short Float8.25%EarningsFeb 28/a
Analyst Recom1.00Target Price88.00
Avg Volume369.09K52W Range27.02 - 73.00
Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Regnante KeithChief Financial OfficerNov 04 '23Option Exercise16.0040,000640,00040,000Jan 08 04:43 PM
Regnante KeithChief Financial OfficerNov 04 '23Sale45.2940,0001,811,6000Jan 08 04:43 PM
Regnante KeithChief Financial OfficerJun 09 '23Option Exercise16.0020,000320,00020,000Jun 12 04:13 PM
Regnante KeithChief Financial OfficerJun 09 '23Sale45.4220,000908,3670Jun 12 04:13 PM
Regnante KeithChief Financial OfficerJun 08 '23Option Exercise16.0020,000320,00020,000Jun 12 04:13 PM
NOAH - Noah Holdings Ltd ADR - Stock Price Chart
TickerNOAH [NYSE]
CompanyNoah Holdings Ltd ADR
CountryChina
IndustryAsset Management
Market Cap839.77MEPS (ttm)12.49
P/E1.02EPS this Y12.12%
Forward P/E5.03EPS next Y11.46%
PEG-EPS past 5Y-0.41%
P/S1.80EPS next 5Y-
P/B0.57EPS Q/Q52.62%
Dividend8.58%Sales Q/Q-10.77%
Insider Own5.03%Inst Own37.67%
Insider Trans0.00%Inst Trans-0.77%
Short Float0.67%EarningsMar 26/a
Analyst Recom1.17Target Price18.93
Avg Volume152.14K52W Range9.90 - 17.39
Noah Holdings Ltd. engages in the provision of investment advisory and wealth management services. It operates through the following segments: Wealth Management, Asset Management, and Other Businesses. The Wealth Management segment offers a global wealth investment and asset allocation services to high net worth individuals and enterprise clients in China. The Asset Management segment manages and develops financial products denominated in both RMB and U.S. dollars, covering real estate funds and funds of funds, including private equity, real estate, secondary market equity, and fixed income funds of funds. The Other Businesses segment operates metrics which include the loan volume and the number of borrowers for lending services business. The company was founded by Jing Bo Wang, Zhe Yin, and Bo Quan He in 2005 and is headquartered in Shanghai, China.
INFU - InfuSystem Holdings Inc - Stock Price Chart
TickerINFU [AMEX, RUT]
CompanyInfuSystem Holdings Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap172.63MEPS (ttm)0.04
P/E205.05EPS this Y341.67%
Forward P/E20.05EPS next Y129.24%
PEG10.25EPS past 5Y-
P/S1.37EPS next 5Y20.00%
P/B3.29EPS Q/Q-34.00%
Dividend-Sales Q/Q10.20%
Insider Own12.24%Inst Own73.12%
Insider Trans0.00%Inst Trans0.37%
Short Float1.15%EarningsMar 14/b
Analyst Recom1.00Target Price14.83
Avg Volume45.22K52W Range7.57 - 11.44
InfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Patient Services and Device Solutions segments. The Patient Services segment involves the durable medical equipment, clinic-to-home health care, logistics and billing, and oncology business. The Device Solutions segment includes the sale or rent of new and pre-owned pole-mounted and ambulatory infusion pumps, treatment-related consumables, biomedical recertification, maintenance and repair services for oncology practices. The company was founded by Steven E. Watkins in August 2005 and headquartered in Rochester Hills, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lachance CarriePresident and COOMar 01 '24Option Exercise0.0050,0000193,745Mar 05 08:00 PM
Chupa AddamExecutive VP and CIOFeb 09 '24Option Exercise0.003,000022,393Feb 13 08:51 PM
Malhotra R. RimmyDirectorSep 06 '23Sale10.0912,500126,07345,000Sep 08 06:38 PM
Malhotra R. RimmyDirectorSep 05 '23Sale10.195,00050,97257,500Sep 05 06:16 PM
Malhotra R. RimmyDirectorSep 01 '23Sale10.2412,500128,03662,500Sep 05 06:16 PM
VFF - Village Farms International, Inc. - Stock Price Chart
TickerVFF [NASD]
CompanyVillage Farms International, Inc.
CountryCanada
IndustryFarm Products
Market Cap149.39MEPS (ttm)-0.29
P/E-EPS this Y74.20%
Forward P/E-EPS next Y71.40%
PEG-EPS past 5Y-11.50%
P/S0.52EPS next 5Y-
P/B0.47EPS Q/Q61.30%
Dividend-Sales Q/Q6.80%
Insider Own9.97%Inst Own16.10%
Insider Trans0.13%Inst Trans-11.55%
Short Float2.24%EarningsMay 08/b
Analyst Recom2.00Target Price1.84
Avg Volume909.34K52W Range0.55 - 1.57
Village Farms International, Inc., together with its subsidiaries, produces, markets, and sells greenhouse-grown tomatoes, bell peppers, and cucumbers in North America. It operates through four segments: Produce, Cannabis-Canada, Cannabis-U.S., and Energy. The company also produces and supplies cannabis products to other licensed providers and provincial governments in Canada and internationally; develops and sells cannabinoid-based health and wellness products, including ingestible, edibles, and topical applications; and produces power. It markets and distributes its products under the Village Farms brand name to retail supermarkets and fresh food distribution companies, as well as products produced under exclusive and non-exclusive arrangements from greenhouse supply partners. The company was formerly known as Village Farms Canada Inc. and changed its name to Village Farms International, Inc. in December 2009. Village Farms International, Inc. was founded in 1989 and is headquartered in Delta, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McLernon John R.DirectorMar 15 '24Buy0.7714,20010,93415,800Apr 12 05:53 PM
LI - Li Auto Inc ADR - Stock Price Chart
TickerLI [NASD]
CompanyLi Auto Inc ADR
CountryChina
IndustryAuto Manufacturers
Market Cap20.41BEPS (ttm)1.54
P/E16.24EPS this Y23.16%
Forward P/E8.91EPS next Y44.27%
PEG0.84EPS past 5Y-
P/S1.17EPS next 5Y19.34%
P/B2.41EPS Q/Q2031.30%
Dividend-Sales Q/Q132.77%
Insider Own1.04%Inst Own11.15%
Insider Trans0.00%Inst Trans-2.92%
Short Float3.27%EarningsFeb 26/b
Analyst Recom1.40Target Price49.02
Avg Volume8.14M52W Range22.23 - 47.33
Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.
CHRO - Chromocell Therapeutics Corp. - Stock Price Chart
TickerCHRO [AMEX]
CompanyChromocell Therapeutics Corp.
CountryUSA
IndustryBiotechnology
Market Cap9.23MEPS (ttm)-1.27
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-436.04%
Dividend-Sales Q/Q-
Insider Own70.67%Inst Own8.28%
Insider Trans0.00%Inst Trans-
Short Float0.06%Earnings-
Analyst Recom-Target Price-
Avg Volume33.83K52W Range1.21 - 6.00
Chromocell Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. The company was founded on March 19, 2021 and is headquartered in Freehold, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davis Todd CDirectorFeb 21 '24Option Exercise4.8029,167140,00229,167Feb 23 05:15 PM
Friedberg Ezra MDirectorFeb 21 '24Option Exercise4.8020,64199,077520,719Feb 23 05:12 PM
110151617181920